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ABSTRACT
Objective: Mebhydrolin napadisylate is classified as an antihistamine drug classes used to treat allergies. One of the quality requirements for drug 
preparation was active compound levels must meet the requirements as stated in the Pharmacopeia or other standard books. The purpose of this 
study was to validate an ultraviolet spectrophotometric method for the determination of mebhydrolin napadisylate in the tablet preparation available 
in the market.
Methods: Solvents used are hydrochloric acid 0.1 N in methanol and sodium hydroxide 0.1 N in methanol for determination of mebhydrolin 
napadisylate and has not been reported. The ultraviolet spectrophotometric method used in the determination of mebhydrolin napadisylate will be 
conducted validation which includes accuracy, precision, linearity, range, limit of detection (LOD), and limit of quantitation (LOQ).
Results: Measurements were made at a maximum wavelength (λmax) of mebhydrolin napadisylate 287 nm. Results of ultraviolet spectrophotometric 
method validation in determination of mebhydrolin napadisylate in tablet preparation; accuracy, precision, linearity, range, LOD, and LOQ meet the 
requirements of validation tests for methods of analysis. The obtained results of the determination of mebhydrolin napadisylate levels in tablet 
preparation with a branded name on the market meet the general requirements of tablet preparation.
Conclusion: Ultraviolet spectrophotometric method of mebhydrolin napadisylate determination in tablet preparation meets the requirements of 
validation tests for methods of analysis. The determination of mebhydrolin napadisylate levels in tablet preparation meets the general requirements 
of tablet preparation.
Keywords: Development, Validation, Ultraviolet spectrophotometric, Mebhydrolin napadisylate.
INTRODUCTION
Mebhydrolin napadisylate is the first generation of an antihistamine 
which is useful for treating allergies, which works to inhibit the 
central nervous system. Antihistamines comprise a broad class of 
pharmacological agents that include the first generation, relatively 
sedating H1 antagonists and second generation, less sedating or 
nonsedating H1 antagonists [1]. In the manufacture of pharmaceuticals, 
examination of the active substance level is a requirement that must 
be met to ensure the quality of drug preparations. Good quality 
medicine, which will support the achievement of the expected 
therapeutic effect. One of the level of quality requirements contained 
levels must meet the requirements as stated in the Pharmacopeia or 
other standard books [2]. Mebhydrolin napadisylate monograph not 
stated in the Indonesian Pharmacopeia, so the level requirements 
used in mebhydrolin napadisylate tablet preparations are general level 
requirements that contain active compounds not less than 90.0% and 
not more than 100.0% of the amount stated on the label.
Based from the structure, mebhydrolin napadisylate having a 
chromophore group and auxochrome group [3]. Compounds which 
have a chromophore group can absorb radiation in the ultraviolet 
region [4-6]. According to Dibbern et al., 2004, mebhydrolin napadisylate 
provides maximum absorbance in aqueous acid solvent at a wavelength 
of 286 nm ( A1
1 =269) and in aqueous base solvent at a wavelength of 
287 nm ( A1
1 =274), so that the mebhydrolin napadisylate levels in tablet 
preparation can be determined by the ultraviolet spectrophotometric 
method [7]. Structure of mebhydrolin napadisylate can be seen in Fig. 1.
Determination of mebhydrolin napadisylate has ever done by 
densitometric method [8], high performance liquid chromatography 
method [9], and visible spectrophotometric method [10] and also has 
been validated the methods of analysis. However, the development and 
validation of ultraviolet spectrophotometric methods for determination 
of mebhydrolin napadisylate in tablet preparations have not been 
reported. Development of ultraviolet spectrophotometric methods is 
required because the method is simple, cheap, and fast [11].
The analytical method used for raw materials or active pharmaceutical 
substances should be able to provide results that can be replicated and 
reliably and to obtain the method used should be validated. Several 
parameter validation should be done, among others, the accuracy, 
precision, linearity, range, specificity, limit of detection (LOD), limit 
of quantitation (LOQ), ruggedness, and robustness [12]. Hence, the 
researchers are interested in determining the validity of the ultraviolet 
spectrophotometric method for determination of mebhydrolin 
napadisylate in tablet preparation using water, methanol, hydrochloric 
acid (HCl) 0.1 N in water, sodium hydroxide (NaOH) 0.1 N in water, 
HCl 0.1 N in methanol, and NaOH 0.1 N in methanol as the solvent. 
The method is validated with the parameters of accuracy, precision, 
linearity, range, LOD, and LOQ. Furthermore, the validated method 
is used to determine the levels of mebhydrolin napadisylate in tablet 
preparation on the market.
METHODS
This research is a descriptive study that aims to determine the validity 
of the ultraviolet spectrophotometric method for the determination of 
mebhydrolin napadisylate in tablet preparation marketed in Medan 
City, North Sumatera Province, Indonesia, whether it meets the general 
level requirements that contain active compounds not less than 90.0% 
and not more than 100.0% of the amount stated on the label.
© 2017 The Authors. Published by Innovare Academic Sciences Pvt Ltd. This is an open access article under the CC BY license (http://creativecommons. 
org/licenses/by/4. 0/) DOI: http://dx.doi.org/10.22159/ajpcr.2017.v10i4.16879
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Tools
The tools used in the research were ultraviolet/visible 
spectrophotometer (Agilent), analytical balance (Boeco), and glassware 
(Iwaki).
Materials
The materials used in the research were HCl, NaOH, methanol 
(CH3OH), mebhydrolin napadisylate reference standard, mebhydrolin 
napadisylate 50 mg tablets preparation with the branded name 
Histapan® (PT. Sanbe), Gabiten® (PT. Ifars), Zoline® (PT. Pyridam), 
Interhistine® (PT. Interbat), Omecidal® (PT. Mutifa).
Preparation of solvents
HCl 0.1 N in methanol
A carefully measured amount of 8.5 ml of HCl, and then diluted in 
methanol to 1000 ml [13].
NaOH 0.1 N in methanol
A carefully weighed amount of 4.0 g of NaOH, and then dissolved in 
methanol to 1000 ml [13].
Preparation of stock solution (SS)
Mebhydrolin napadisylate reference standard was weighed carefully 
the amount of 50.0 mg, put in a 100.0 ml volumetric flask, added 60.0 ml 
solvent, shaken until mebhydrolin napadisylate dissolved, diluted with a 
solvent to mark lines, shaken until homogeneous, obtained the mixture 
with a concentration of mebhydrolin napadisylate 500.00 µg/mL, this 
solution is called SS I. The SS I pipetted amount of 15.0 ml, put in a 
200.0 ml volumetric flask, diluted with a solvent to mark lines, shaken 
until homogeneous, obtained the solution with a concentration of 
mebhydrolin napadisylate 37.50 µg/mL, this solution is called SS II.
Determination maximum absorbance (Amax) and maximum 
wavelength (λmax)
The SS II pipetted amount of 4.0 ml, put in a 10.0 ml volumetric flask, 
diluted with a solvent to mark lines, shaken until homogeneous, 
obtained the solution with a concentration of mebhydrolin napadisylate 
15.00 µg/mL, then measured the absorbance of the solution at the 
wavelength range of 200 nm to 400 nm. A solvent used as a blank, 
then the specified maximum absorbance (Amax) and the maximum 
wavelength (λmax) [14].
Determination of linearity, LOD, and LOQ
The SS II pipetted amount of 2.0, 3.0, 4.0, 5.0, and 6.0 ml, each put 
in a 10.0 ml volumetric flask, each diluted with a solvent to mark 
lines, each shaken until homogeneous, obtained the solution with a 
concentration of mebhydrolin napadisylate, respectively, 7.50, 11.25, 
15.00, 18.75, and 22.50 µg/mL, then measured the absorbance of the 
solution at maximum wavelength (λmax) obtained. A solvent used as a 
blank, then calculated the coefficient of correlation (r), coefficient of 
determination (r2), regression line equation, LOD, and LOQ [15].
a
XY X Y n
X X n
=
∑ − ∑ × ∑
∑ − ∑
( ) ( )/
( ) /
2 2
b Y a X= − ×
r=
XY X Y n
X X n Y Y n
( ) ( ) ( )/
[( ) ( ) / ][( ) ( ) / ]
∑ − ∑ × ∑
∑ − ∑ ∑ − ∑2 2 2 2
r
XY X) ( Y) / n
X X n Y Y n
2
2 2 2 2
=
∑ − ∑ × ∑













































Determination of mebhydrolin napadisylate levels in tablet 
preparation
Not <20 tablets were weighed and powdered, weighed carefully the 
amount of powder equivalent to 50.0 mg mebhydrolin napadisylate 
(weighing powders as much as 6 times repetition), put in a 100.0 ml 
volumetric flask, added 60.0 ml solvent, shaken until mebhydrolin 
napadisylate dissolved, diluted with a solvent to mark lines, shaken 
until homogeneous, obtained the mixture with a concentration of 
mebhydrolin napadisylate 500.00 µg/mL. The mixture was filtered 
through a funnel and filter paper, removed 20 ml of the first filtrate was, 
accommodated the later filtrate, discarded residue, pipetted amount 
of 15.0 ml filtrate, put in a 200.0 ml volumetric flask, diluted with a 
solvent to mark lines, shaken until homogeneous, obtained the solution 
with a concentration of mebhydrolin napadisylate 37.50 µg/mL. The 
solution was pipetted amount of 4.0 ml, put in a 10.0 ml volumetric 
flask, diluted with a solvent to mark lines, shaken until homogeneous, 
obtained the solution with a concentration of mebhydrolin napadisylate 
15.00 µg/mL, then measured the absorbance of the solution at 
maximum wavelength (λmax) obtained. A solvent used as a blank, then 
calculated the concentration mebhydrolin napadisylate in the sample 
solution using the regression line equation, and the calculated levels 
of mebhydrolin napadisylate in tablet preparation. Calculated the 
standard deviation (SD), determination of the data received or rejected 
using the calculated T value (Tcalc), determination of actual level (μ) of 
















Fig. 1: Structure of mebhydrolin napadisylate
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Determination of accuracy and precision
Accuracy test and precision test conducted on mebhydrolin napadisylate 
tablet samples in tablet preparation under the branded name Zoline® 
(PT. Pyridam). Accuracy test conducted by standard addition method to 
create a specific range of analyte concentrations with 80.00%, 100.00%, 
and 120.00% calculated from the amount of mebhydrolin napadisylate 
stated on the label, each specific range performed 3 times repetition. 
Each specific range containing 70% of samples and 30% of reference 
standards, then analyzed with the same treatment as the sample assay. 
Determination of the accuracy of the analysis method is determined 
by calculation of recovery percentage (% Recovery) after addition of 
the mebhydrolin napadisylate reference standard in the mebhydrolin 
napadisylate tablet sample [16]. Precision test is done by calculating 
the relative SD (RSD) of the percentage of the recovery percentage 












A=Analyte mass after the standard addition,




X =Average of recovery percentage.
RESULTS AND DISCUSSIONS
According to Dibbern et al., 2004, mebhydrolin napadisylate has a 
maximum absorbance spectrum in the ultraviolet region in an acid 
solution at a wavelength of 286 nm ( A1
1 =269) and in a base solution 
at a wavelength of 287 nm ( A1
1 =274). Previously, researchers done 
orientation of determination of mebhydrolin napadisylate with several 
solvents, using water, methanol, HCl 0.1 N in water, NaOH 0.1 N in 
water, HCl 0.1 N in methanol, and NaOH 0.1 N in methanol. However, 
mebhydrolin napadisylate not completely soluble in water, methanol, 
HCl 0.1 N in water, and NaOH 0.1 N water. Using HCl, 0.1 N in methanol 
and NaOH 0.1 N in methanol as a solvent, it turns out mebhydrolin 
napadisylate dissolve completely, so the researchers used HCl 0.1 N in 
methanol and NaOH 0.1 N in methanol as solvent in this research.
Determination maximum absorbance (Amax) and maximum 
wavelength (λmax)
Determination of mebhydrolin napadisylate in tablet preparation, 
beginning with the determination of the maximum wavelength 
even though the maximum wavelength (λmax) is already known from 
literature for the maximum wavelength (λmax) of a compound can 
differ when determined by the different conditions (solvent) and 
tools. Determination of the wavelength is performed in the solvent 
HCl 0.1 N in methanol and in the solvent NaOH 0.1 N in methanol at 
a concentration that gives absorbance with the smallest photometric 
error, which is ±0.4. Determination of the maximum wavelength with a 
concentration of 15 µg/mL which provides absorbance approaching 0.4. 
Absorbance spectrum and absorbance spectrum data of mebhydrolin 
napadisylate in the solvent HCl 0.1 N in methanol and in the solvent 
NaOH 0.1 N in methanol can be seen in Fig. 2 and Table 1.
Mebhydrolin napadisylate absorbance spectrum in the solvent HCl 0.1 N 
in methanol and in the solvent NaOH 0.1 N in methanol showed only one 
peak. Maximum absorbance (Amax) and maximum wavelength (λmax) of 
mebhydrolin napadisylate show that the maximum absorbance (Amax) 
of mebhydrolin napadisylate in the solvent HCl 0.1 N in methanol is 
0.40557 with the maximum wavelength (λmax) 287 nm and maximum 
absorbance (Amax) of mebhydrolin napadisylate in the solvent NaOH 
0.1 N in methanol is 0.41223 with the maximum wavelength (λmax) 
287 nm. Maximum wavelength (λmax) obtained from measurements 
similar to the maximum wavelength (λmax) obtained from literature 
(287 nm) in the base solvent, but maximum wavelength (λmax) obtained 
from measurements different 1 nm compared to the maximum 
wavelength (λmax) obtained from literature (286 nm) in the acid solvent. 
This result is still in the allowed range, the maximum wavelength (λmax) 
difference between the measurement results and the literature is not 
more than 2 nm [18]. Furthermore, determination of mebhydrolin 
napadisylate in tablet preparation on the market is done at a maximum 
wavelength (λmax) obtained.
Determination of linearity, LOD, and LOQ
Linearity determination of the mebhydrolin napadisylate calibration 
curve is done with the concentration range of 7.5-22.5 µg/mL at a 
wavelength of 287 nm using HCl 0.1 N in methanol and NaOH 0.1 N in 
methanol as a solvent and a blank. The curve calibration and calibration 
curve data of mebhydrolin napadisylate in the solvent HCl 0.1 N in 
methanol and in the solvent NaOH 0.1 N in methanol can be seen in 
Fig. 3 and Table 2.
The results of the mebhydrolin napadisylate calibration curve 
measurements in the solvent HCl 0.1 N in methanol with the concentration 
range of 7.5-22.5 µg/mL at a wavelength of 287 nm obtained linear 
Table 1: Absorbance spectrum data of mebhydrolin 
napadisylate absorbance spectrum (concentration of 15 µg/mL) 
in the solvent HCl 0.1 N in methanol and in the solvent 
NaOH 0.1 N in methanol
S.No. Wavelength Absorbance Solvent
1 287 nm 0.40577 HCl 0.1 N in methanol
2 287 nm 0.41223 NaOH 0.1 N in methanol
HCl: Hydrochloric acid, NaOH: Sodium hydroxide
Table 2: Calibration curve data of mebhydrolin napadisylate in 
the solvent HCl 0.1 N in methanol and in the solvent NaOH 0.1 N 
in methanol
S.No Concentration Absorbance
HCl 0.1 N in 
methanol
NaOH 0.1 N in 
methanol
1 0.00 µg/mL 0.00000 0.00000
2 7.50 µg/mL 0.20289 0.20614
3 11.25 µg/mL 0.30432 0.30921
4 15.00 µg/mL 0.40579 0.41226
5 18.75 µg/mL 0.50731 0.51530
6 22.50 µg/mL 0.60873 0.61841
HCl: Hydrochloric acid, NaOH: Sodium hydroxide
370
Asian J Pharm Clin Res, Vol 10, Issue 4, 2017, 367-372
 Nerdy 
relationship between concentration and absorbance with the coefficient 
of correlation (r)=0.9999999923 and the coefficient of determination 
(r2)=0.9999999847. The correlation coefficient obtained has met the 
requirements, the acceptance criteria for the correlation coefficient is 
r≥0.995 [3]. The calculation result of the regression line equation obtained 
the regression line equation Y=0.0272555810 × X − 0.0000214286. 
From the calibration curve, data can be calculated that determination of 
mebhydrolin napadisylate by an ultraviolet spectrophotometric method 
in the solvent HCl 0.1 N in methanol has the LOD of 0.0015 µg/mL and the 
LOQ of 0.0046 µg/mL. All the measurement concentration must above the 
LOD and LOQ to meet the requirements of accuracy and precision [19].
The results of the mebhydrolin napadisylate calibration curve 
measurements in the solvent NaOH 0.1 N in methanol with the 
concentration range of 7.5-22.5 µg/mL at a wavelength of 287 nm 
obtained linear relationship between concentration and absorbance 
with the coefficient of correlation (r)=0.9999999974 and the 
coefficient of determination (r2)=0.9999999948. The correlation 
coefficient obtained has met the requirements, the acceptance criteria 
for the correlation coefficient is r≥0.995 [3]. The calculation result of 
the regression line equation obtained the regression line equation 
Y = 0.0274839238 × X + 0.0000042857. From the calibration curve, data 
can be calculated that the determination of mebhydrolin napadisylate 
by an ultraviolet spectrophotometric method in the solvent NaOH 0.1 N 
in methanol has the LOD of 0.0009 µg/mL and the LOQ of 0.0027 µg/mL. 
All the measurement concentrations must above the LOD and LOQ to 
meet the requirements of accuracy and precision [19].
Determination of mebhydrolin napadisylate levels in tablet 
preparation
Determination of mebhydrolin napadisylate in a tablet preparation results 
and recapitulation of mebhydrolin napadisylate levels to determine 
the mebhydrolin napadisylate level in Histapan® (PT. Sanbe), Gabiten® 
(PT. Ifars), Zoline® (PT. Pyridam), Interhistine® (PT. Interbat), and 
Omecidal® (PT. Mutifa) in the solvent HCl 0.1 N in methanol and in the 
solvent NaOH 0.1 N in methanol can be seen, respectively, in Tables 3 and 4.
Determination of mebhydrolin napadisylate results showed that the 
levels of mebhydrolin napadisylate in tablet preparation in the solvent 
HCl 0.1 N in methanol and in the solvent NaOH 0.1 N in methanol with a 
branded name on the market meet the general level requirements that 
contains active compounds not <90.0% and not more than 100.0% of 
the amount stated on the label.
Determination of range, accuracy and precision
Accuracy test conducted by standard addition method on Zoline® 
(PT. Pyridam) samples tablets with recovery percentage (% recovery) 
parameter. Precision test is done by calculating the RSD of the percentage 
Fig. 2: Absorbance spectrum of mebhydrolin napadisylate (concentration of 15 µg/mL) in the solvent hydrochloric acid 0.1 N in 
methanol (a) and in the solvent sodium hydroxide 0.1 N in methanol (b)
a b
Fig. 3: Calibration curve of mebhydrolin napadisylate in the solvent hydrochloric acid 0.1 N in methanol (a) and in the solvent sodium 
hydroxide 0.1 N in methanol (b) at a wavelength of 287 nm
a b
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of the recovery percentage (% recovery) that has been obtained from 
the accuracy test. Accuracy test with recovery percentage (% recovery) 
parameter is done by making three concentrations of the samples with 
a specific range 80.00%, 100.00%, and 120.00% was calculated from 
the levels mebhydrolin napadisylate stated on the label, where each 
specific range was done with three repetitions, and each specific range 
contains 70% of samples and 30% reference standards. Solvents used 
in accuracy test and precision test were HCl 0.1 N in methanol and 
NaOH 0.1 N in methanol. Tables 5 and 6 showed the accuracy test and 
precision test result data on ultraviolet spectrophotometric method for 
the determination of mebhydrolin napadisylate in tablet preparations 
in the solvent HCl 0.1 N in methanol and in the solvent NaOH 0.1 N in 
methanol with standard addition method.
Accuracy test result with recovery percentage (% recovery) parameter 
in ultraviolet spectrophotometric method for determination of 
mebhydrolin napadisylate in tablet preparations in the solvent HCl 
0.1 N in methanol and in the solvent NaOH 0.1 N in methanol with 
standard addition method obtained recovery percentage (% recovery), 
respectively, 100.03% and 100.21%. This accuracy result meets the 
accuracy requirements, where the value of the recovery percentage 
(% recovery) is permitted between 98.0% and 102.0%. Precision test 
result with RSD parameter in ultraviolet spectrophotometric method for 
determination of mebhydrolin napadisylate in tablet preparations in the 
solvent HCl 0.1 N in methanol and in the solvent NaOH 0.1 N in methanol 
with standard addition method obtained RSD, respectively, 0.03% and 
0.18%. This precision result meets the precision requirements, where 
the value of the RSD is permitted not more than 2% [16]. The lower 
concentration of accuracy test was 80.00% from the test concentration 
(15.00 µg/mL) and the higher concentration of accuracy test was 
120.00% from the test concentration (15.00 µg/mL). The range obtained 
from the method validation was 12.00-18.00 µg/mL for both solvents.
Method validation
The validation test results of ultraviolet spectrophotometric method 
for determination of mebhydrolin napadisylate in tablet preparations 
Table 3: Mebhydrolin napadisylate level in tablet preparation 










1 Histapan® (PT. Sanbe) 99.22 99.22±0.25
2 Gabiten® (PT. Ifars) 98.98 98.98±0.38
3 Zoline® (PT. Pyridam) 99.62 99.62±0.23
4 Interhistine® (PT. Interbat) 99.44 99.44±0.30
5 Omecidal® (PT. Mutifa) 99.52 99.52±0.20
HCl: Hydrochloric acid
Table 4: Mebhydrolin napadisylate level in tablet preparation 
results in the solvent NaOH 0.1 N in methanol







1 Histapan® (PT. Sanbe) 99.45 99.45±0.51
2 Gabiten® (PT. Ifars) 98.39 98.39±0.22
3 Zoline® (PT. Pyridam) 99.83 99.83±0.27
4 Interhistine® (PT. Interbat) 99.57 99.57±0.44
5 Omecidal® (PT. Mutifa) 99.67 99.67±0.37
NaOH: Sodium hydroxide
Table 5: Accuracy test and precision test result data on ultraviolet spectrophotometric method for determination of mebhydrolin 
napadisylate in tablet preparations in the solvent HCl 0.1 N in methanol with standard addition method
No Specific range (%) Absorbance Analyte mass (mg) Recovery 
percentageBefore the standard 
addition
After the standard 
addition
Before the standard 
addition




1 80.00 0.22751 0.32488 28.0326 40.0289 11.98680 100.08
2 0.22797 0.32527 28.0893 40.0769 100.01
3 0.22768 0.32497 28.0535 40.0400 100.00
4 100.00 0.28487 0.40651 35.0995 50.0860 14.98350 100.02
5 0.28446 0.40612 35.0490 50.0379 100.04
6 0.28415 0.40588 35.0108 50.0083 100.09
7 120.00 0.34105 0.48705 42.0211 60.0087 17.98020 100.04
8 0.34144 0.48739 42.0691 60.0506 100.01
9 0.34168 0.48765 42.0987 60.0827 100.02
Average % Recovery (%) 100.03
RSD (%) 0.03
HCl: Hydrochloric acid, RSD: Relative standard deviation
Table 6: Accuracy test and precision test result data on ultraviolet spectrophotometric method for determination of mebhydrolin 
napadisylate in tablet preparations in the solvent NaOH 0.1 N in methanol with standard addition method
No Specific range Absorbance Analyte mass (mg) Recovery 
percentageBefore the standard 
addition
After the standard 
addition
Before the standard 
addition




1 80.00% 0.23102 0.32999 28.0183 40.0217 11.98680 100.14
2 0.23094 0.33018 28.0086 40.0447 100.41
3 0.23108 0.33002 28.0256 40.0253 100.11
4 100.00% 0.28882 0.41291 35.0284 50.0785 14.98350 100.44
5 0.28894 0.41247 35.0430 50.0251 99.99
6 0.28887 0.41265 35.0345 50.0469 100.19
7 120.00% 0.34612 0.49501 41.9780 60.0358 17.98020 100.43
8 0.34635 0.49488 42.0059 60.0200 100.19
9 0.34657 0.49475 42.0325 60.0043 99.95
Average % recovery (%) 100.21
RSD (%) 0.18
NaOH: Sodium hydroxide, RSD: Relative standard deviation 
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in the solvent HCl 0.1 N in methanol and in the solvent NaOH 0.1 N in 
methanol with the test parameters: accuracy, precision, linearity, range, 
LOD, and LOQ showed that ultraviolet spectrophotometric method 
is valid for determination of mebhydrolin napadisylate in tablet 
preparations in the solvent HCl 0.1 N in methanol and in the solvent 
NaOH 0.1 N in methanol. Determination of mebhydrolin napadisylate 
has ever done by densitometric method [8], high performance 
liquid chromatography method [9], and visible spectrophotometric 
method [10] and also has been validated the methods of analysis. In this 
study, the researcher obtained the valid ultraviolet spectrophotometric 
method that is simpler, cheaper, and faster than previously validated 
methods (densitometric, high performance liquid chromatography, and 
visible spectrophotometric.
CONCLUSIONS
From the research, mebhydrolin napadisylate in tablet preparation 
can be determined using the ultraviolet spectrophotometric method 
using the solvent HCl 0.1 N in methanol and the solvent NaOH 0.1 N in 
methanol at a wavelength of 287 nm. The results of the analysis method 
validation test with accuracy, precision, linearity, range, LOD, and LOQ 
meet the requirements. Mebhydrolin napadisylate assay showed that 
all the tablets analyzed with the branded name Histapan® (PT. Sanbe), 
Gabiten® (PT. Ifars), Zoline® (PT. Pyridam), Interhistine® (PT. Interbat), 
and Omecidal® (PT. Mutifa) meet the general level requirements that 
contain active compounds not <90.0% and not more than 100.0% of the 
amount stated on the label.
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